Proteochemometric modeling in a Bayesian framework
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Proteochemometrics (PCM) is an approach for bioactivity predictive modeling which models the relationship between protein and chemical information. Gaussian Processes (GP), based on Bayesian inference, provide the most objective estimation of the uncertainty of the predictions, thus permitting the evaluation of the applicability domain (AD) of the model. Furthermore, the experimental error on bioactivity measurements can be used as input for this probabilistic model. In this study, we apply GP implemented with a panel of kernels on three various (and multispecies) PCM datasets. The first dataset consisted of information from 8 human and rat adenosine receptors with 10,999 small molecule ligands and their binding affinity. The second consisted of the catalytic activity of four dengue virus NS3 proteases on 56 small peptides. Finally, we have gathered bioactivity information of small molecule ligands on 91 aminergic GPCRs from 9 different species, leading to a dataset of 24,593 datapoints with a matrix completeness of only 2.43%. GP models trained on these datasets are statistically sound, at the same level of statistical significance as Support Vector Machines (SVM), with R02 values on the external dataset ranging from 0.68 to 0.92, and RMSEP values close to the experimental error. Furthermore, the best GP models obtained with the normalized polynomial and radial kernels provide intervals of confidence for the predictions in agreement with the cumulative Gaussian distribution. GP models were also interpreted on the basis of individual targets and of ligand descriptors. In the dengue dataset, the model interpretation in terms of the amino-acid positions in the tetra-peptide ligands gave biologically meaningful results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · cited 2×
“…GP models are validated by comparing their performance to that of SVM using a panel of kernels on two PCM datasets extracted from ChEMBL database, [39] involving adenosine receptors (10,999 data points, 8 sequences) and aminergic GPCRs (24,593 data points, 91 sequences), and on a third dataset…”
MethodGolbraikh, A., & Tropsha, A. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00123-1 · Cited by 3,735 · cited 2×
“R 2 or Q 2 ) [27-29] while also providing individual assessment for predictions.”
BackgroundMethodInternational Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667 · cited 1×
“These techniques are based on the similarity principle [4,5], which follows the premise that similar compounds (and targets) [6] are more likely to exhibit akin bioactivity profiles in comparison to structurally distant structures.”
BackgroundChemical substructures that enrich for biological activity
Klekota, J., & Roth, F. P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn479 · Cited by 392 · cited 1×
“…here, display alternatively the following properties: (i) they are not implicated in compound bioactivity as their presence or absence does not influence compounds bioactivity, (ii) their contribution to the pK i values, is conditioned to the presence or absence of other substructures [70].”
Backgroundvan Westen, G. J. P., Wegner, J. K., IJzerman, A. P., van Vlijmen, H. W. T., & Bender, A. (2011) · MedChemComm · doi:10.1039/c0md00165a · Cited by 176
Self-citation
Cited by
ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation
Dong, J., Cao, D.-S., Miao, H.-Y., Liu, S., Deng, B.-C., Yun, Y.-H., Wang, N.-N., Lu, A.-P., Zeng, W.-B., & Chen, A. F. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0109-z · Cited by 404
Use of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254
Interpretation of Quantitative Structure-Activity Relationship Models: Past, Present, and Future
Polishchuk, P. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00274 · Cited by 236
Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction
Russo, D. P., Zorn, K. M., Clark, A. M., Zhu, H., & Ekins, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00546 · Cited by 152
Reliable Prediction Errors for Deep Neural Networks Using Test-Time Dropout
Cortés-Ciriano, I., & Bender, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00297 · Cited by 51
Self-citation
Metadata
- Authors
- Cortes-Ciriano, I., van Westen, G. J., Lenselink, E. B., Murrell, D. S., Bender, A., & Malliavin, T.
- Venue
- Journal of Cheminformatics
- Published
- 2014-06-28
- Volume
- 6
- Issue
- 1
- Pages
- 35-35
- ISSN
- 1758-2946 (ISSN-L)
- OpenAlex
- W2144377773
- Cited by
- 45
- References
- 6
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proteochemometric modeling in a Bayesian framework. https://app.cochat.ai/papers/10.1186/1758-2946-6-35
- The paper
- Cortes-Ciriano, I., van Westen, G. J., Lenselink, E. B., Murrell, D. S., Bender, A., & Malliavin, T. (2014). Proteochemometric modeling in a Bayesian framework. Journal of Cheminformatics. https://doi.org/10.1186/1758-2946-6-35
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.